documents: FDA-2023-N-4201-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-4201-0001 | FDA | FDA-2023-N-4201 | Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Implied Claims in Direct-to-Consumer Prescription Drug Promotion | Notice | 60 Day Proposed Information Collection | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2024-02-21T04:59:59Z | 2024-02-21T02:00:37Z | 2023-28093 | 0 | 0 | 090000648634dc45 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref